Prospective epidemiological studies reinforce the relationship between metabolic dysfunction and mood disorders [21,43]
Food and Drug Administration (FDA) in 2005 for the treatment of type 2 diabetes
The reduction correlates with overall weight loss, typically 10-15% of body weight with higher-dose formulations
Keep reading Published on: April 01, 2022 Redefining Healing Experiences with Sound at South by Southwest Each year a diverse group of artists, entrepreneurs and technologists join policy and business thought leaders from around the globe in Austin, Texas, for the South by Southwest conference and festival
doi: 10.3803/EnM.2021.102 Summary Keywords GLP-1 receptor agonists, endocrine, cardiovascular, neurological, cancer Citation Zhao X, Wang M, Wen Z, Lu Z, Cui L, Fu C, Xue H, Liu Y and Zhang Y (2021) GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects